Why the study?
Chronic obstructive pulmonary disease is a leading cause of early readmissions, and financial penalties prompted the evaluation of a collaborative to support hospitals in reducing preventable revisits.
Does a COPD Chronic Care Management Collaborative reduce COPD-related ED and hospital revisits in U.S. hospitals?
Does a COPD Chronic Care Management Collaborative reduce COPD-related ED and hospital revisits in U.S. hospitals?
A 6-month COPD Chronic Care Management Collaborative supported the majority of participating hospitals in reducing COPD-related ED and/or hospital revisits.
May support COPD care collaboratives at participating sites; leaves open generalizability and causality beyond this Level 3 cohort.
Background: Chronic obstructive pulmonary disease (COPD) is the third-leading cause of early readmissions. The Centers for Medicare and Medicaid instituted a financial penalty for excessive COPD readmissions galvanizing hospitals to implement effective strategies to reduce readmissions. We evaluated a 6-month COPD Chronic Care Management Collaborative to support hospitals to reduce preventable COPD-related revisits. Methods: Sites were recruited among nearly 300 Vizient, Inc., members. The Collaborative used performance improvement initiatives to assist with implementation of effective strategies. Participants submitted performance data for 2 outcome measures: emergency department (ED) and hospital revisits. Results: Forty-seven members enrolled (Part I+II: n=33; Part I: n=3; Part II: n=11) of which 23 submitted data (n=23/47). The majority (n=19/23, 83%) reduced rates of COPD-related ED and/or hospital revisits. Among all 23 sites, the change in ED visits went from 11.05% to 10.87%; among 7 sites with reductions in ED visits, the reduction was 12.7% to 9%. Among all 23 sites, there were not reductions in hospital readmissions (18.53% to 18.64%); among 7 sites with reductions, the readmission rate went from 20.1% to 15.6%. The mean reach across 17 hospitals reporting reach for their most successful measure at baseline was 35.2% (SD=26.7%) and for the other 6, reporting reach at follow-up was 73.8%% (SD=18.3%); of note, only 3 sites submitted both baseline and follow-up data. Conclusions: The Collaborative successfully supported the majority of sites in reducing COPD-related ED and/or hospital revisits using subject matter experts and coaching strategies to support hospitals' implementation of COPD quality improvement interventions.
No takes yet. Share an insight, caveat, or question.
Press et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: